Crossmark

Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Crossref DOI link: https://doi.org/10.1186/s13613-022-01059-9

Published Print: 2022

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chabert, Paul https://orcid.org/0000-0001-8697-6415
Provoost, Judith

Cohen, Sabine

Dupieux-Chabert, Céline

Bitker, Laurent

Ferry, Tristan

Goutelle, Sylvain

Richard, Jean-Christophe
License Information

Text and Data Mining valid from 2022-01-01

Text and Data Mining valid from 2022-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-022-01059-9

Content Type: article

Copyright: Copyright © 2022 The Author(s) 2022. Published by Elsevier Masson SAS

Document is current

Any future updates will be listed below